top of page
11β-Hydroxysteroid dehydrogenase type 1 inhibition protects against the development of adverse metabolic and bone effects of prednisolone: A randomized, double-blind, placebo-controlled trial.
European Society of Endocrinology
9/7/20, 5:00 PM
Europe/Paris GMT+2
Description
Speakers
Nantia Othonos
Speakers
Link to Event
Banner
Register your event here
Already have an account? LOGIN HERE. If You don't have an account you need to create a free account.
Registro
bottom of page